Ventas/$VTR

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Ventas

Ventas owns a diversified healthcare portfolio of almost 1,400 in-place properties spread across the senior housing, medical office, hospital, life science, and skilled nursing/post-acute care. The portfolio includes almost 100 properties in Canada and the United Kingdom as the company looks for additional investment opportunities in countries with mature healthcare systems that operate similarly to the United States. The firm also owns mortgages and other loans, contributing about 1% of net operating income.

Ticker

$VTR

Primary listing

NYSE

Industry

Health Care REITs

Employees

498

ISIN

US92276F1003

Ventas Metrics

BasicAdvanced
$30B
200.91
$0.33
0.97
$1.86
2.92%

What the Analysts think about Ventas

Analyst ratings (Buy, Hold, Sell) for Ventas stock.

Bulls say / Bears say

Ventas reported a 13.2% year-over-year increase in revenue for Q1 2025, reaching $1.36 billion, surpassing analyst expectations of $1.32 billion. (reuters.com)
The company secured new lease agreements with Kindred Healthcare and its parent companies for 23 long-term acute care hospitals, enhancing its healthcare portfolio. (investing.com)
Analysts have shown confidence in Ventas, with Deutsche Bank upgrading its price target to $70 from $55, maintaining a Buy rating. (investing.com)
Ventas announced a public offering of 10.6 million shares, potentially diluting existing shareholders' value. (investing.com)
The company reported a net income of $46.87 million in Q1 2025, which, while positive, may not meet some investors' expectations for higher profitability. (reuters.com)
Wells Fargo & Company reduced its stock position in Ventas, indicating potential concerns about the company's future performance. (marketbeat.com)
Data summarised monthly by Lightyear AI. Last updated on 12 Jul 2025.

Ventas Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Ventas Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $VTR

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs